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Abstract: Patients with multimorbidity (defined as the co-occurrence of multiple chronic diseases)
frequently experience fragmented care, which increases the risk of negative outcomes. A recently
proposed Integrated Multimorbidity Care Model aims to overcome many issues related to fragmented
care. In the context of Joint Action CHRODIS-PLUS, an implementation methodology was developed
for the care model, which is being piloted in five sites. We aim to (1) explain the methodology
used to implement the care model and (2) describe how the pilot sites have adapted and applied
the proposed methodology. The model is being implemented in Spain (Andalusia and Aragon),
Lithuania (Vilnius and Kaunas), and Italy (Rome). Local implementation working groups at each site
adapted the model to local needs, goals, and resources using the same methodological steps: (1) Scope
analysis; (2) situation analysis—“strengths, weaknesses, opportunities, threats” (SWOT) analysis;
(3) development and improvement of implementation methodology; and (4) final development of
an action plan. This common implementation strategy shows how care models can be adapted
according to local and regional specificities. Analysis of the common key outcome indicators at the
post-implementation phase will help to demonstrate the clinical effectiveness, as well as highlight
any difficulties in adapting a common Integrated Multimorbidity Care Model in different countries
and clinical settings.
Keywords: multimorbidity; chronic disease; non-communicable diseases; integrated care; care model;
Europe; care manager; individualized care plans; comprehensive assessment
1. Introduction
1.1. The Challenge of Multimorbidity
Multimorbidity is the co-occurrence of multiple chronic diseases or conditions in a single individual.
It has been described as the most common chronic condition, as it has a high prevalence, especially in
older individuals, where it affects more than 60% of people aged 65 or over [1]. Some multimorbidity
patients can be complex, particularly because they are more likely to have problems with mobility,
self-care, and daily functioning than patients with one chronic disease, as well as cognitive impairment
and frailty [2]. This often results in more challenging healthcare treatment. Many healthcare systems
still focus on a traditional disease-oriented approach. Consequently, multimorbid patients frequently
experience fragmented care [3,4] and receive complex drug regimens and polypharmacy, which increase
the risk of inappropriate prescribing, adverse drug reactions, and poor medication adherence [5].
[JA CHRODIS PLUS]—the Joint Action (JA) CHRODIS-PLUS: Implementing good practices for
chronic diseases (JA-CHRODIS-PLUS)
[JA CHRODIS]—the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the
Life Cycle (JA-CHRODIS)
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1.2. The Integrated Multimorbidity Care Model
An Integrated Multimorbidity Care Model [6] was recently proposed, which aims to overcome
many of the issues related to fragmented care. The model was developed as part of the Joint Action
(JA) on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (CHRODIS) [7] and
focuses on several limitations currently faced in the treatment of multimorbid patients. It recognizes
that fragmented care may be due to a lack of integration between primary and hospital care services as
well as between healthcare professionals from different specialties or disciplines. Currently, although
many healthcare professionals are well trained to manage single chronic diseases by following official
clinical guidelines for specific diseases, they are not specifically trained to handle patients with
multimorbidity. They also may be inexperienced in terms of adopting patient-centered care and
shared-decision making that takes the patient’s preferences, needs, and expectations into account.
The Integrated Multimorbidity Care Model, therefore, proposes 16 components for the care and
treatment of multimorbid patients. These components are categorized into five domains: Delivery of
care; decision support; self-management support; information systems and technology; and social and
community resources. Much of the basic structure of the model is based on Wager et al.’s Chronic
Care Model [8,9] and was adapted to the specific needs of multimorbid patients, based on scientific
evidence combined with the opinions of international experts. However, the model has not been tested
in real-life clinical practice until now. In 2016 a systematic review [10] found only 19 publications in
the scientific literature that assessed integrated care models for multimorbidity and only one of these
was from Europe. Palmer et al. [6] highlighted that the applicability of the JA CHRODIS Integrated
Multimorbidity Care Model will depend on type of health and care service system of the country and
that the guidelines should be interpreted and applied according to the specific setting. The current
paper describes the development of a methodology to operationalize principles described in the model
and its application to various clinical settings in different European countries.
1.3. Pilot Implementation of the Integrated Multimorbidity Care Model: Joint Action CHRODIS-PLUS
The JA CHRODIS-PLUS on Implementing Good Practices for Chronic Diseases [11] is a three-year
project funded by the European Union that aims to support European member states through the
implementation of cross-national policies and practices with demonstrated success to reduce the
burden of chronic disease identified in JA CHRODIS. One of the main objectives of JA CHRODIS-PLUS
is to develop a methodology to implement the Integrated Multimorbidity Care Model. This led to
the definition of a framework for the care of patients with multimorbidity that could potentially be
adapted and applied in local practices in Europe [6]. Such a methodology is then applied in pilot sites
and its effectiveness on clinical and process outcomes is tested.
1.4. Aims and Objectives
In the context of JA CHRODIS-PLUS, an implementation methodology was developed, which is
currently being piloted in five sites in Spain, Lithuania, and Italy, where the model is adapted and
implemented according to local practices. The aim of the current paper is to (i) explain the methodology
used to implement the Integrated Multimorbidity Care Model and (ii) describe the five pilot sites and
how they have adapted and applied the proposed methodology for local implementation.
2. Methods
2.1. Survey to Assess Characteristics of the Pilot Sites
At the start of the project, a survey was designed to assess characteristics of the five sites that would
be participating in the implementation. JA CHRODIS-PLUS partners designed a questionnaire to collect
information about the organizations and their planned care model programs, across six dimensions:
(1) General information; (2) delivery of care and decision support; (3) patient self-management;
(4) eHealth; (5) community resources; and (6) practice/program assessment. After the development of
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the questionnaire, an online version was made accessible to partners. The survey was used to identify
common characteristic of the five pilot sites as well as to explore their differences.
2.2. Patient Risk Stratification Strategies
Pilot sites were asked to adopt a risk stratification process to ensure that care coordination would
focus on patients who would benefit the most, thus maximizing the impact on both quality and costs.
Risk stratification is defined as a systematic process to target, identify, and select patients who are at
risk of poorer health outcomes, and who are expected to benefit most from an intervention [12–14].
The process groups the population according to different risk levels and needs based on how likely
people are to use services and resources and also helps identify practices where improvement
is necessary.
Each of the five pilot sites first defined a target cohort of persons who were at risk of poorer health
outcomes and considered a priority for targeting with different or additional interventions. They
identified individuals within the target cohort by searching databases that routinely collect information
on clinical or demographic data. Individuals were then selected by healthcare professionals according
to their need for the integrated care intervention.
2.3. Implementation Strategy
A common implementation strategy was developed for all the implementation pilot sites, which
aimed to provide guidelines to facilitate the uptake of routine good practices, policies, and tools.
This implementation strategy was designed by JA CHRODIS-PLUS coordinators, partners, and other
dedicated experts.
As a first step, each of the five sites established a local implementation working group comprised of
beneficiaries, collaborative care providers, and local stakeholders. Although the composition of the local
implementation working group could differ between sites, all of them had to include a core set of persons
in the team, specifically: Organizer, experts, decision makers, front line stakeholders, and implementers
(see Table 1). The working groups involved periodic face-to-face meetings (when this was not possible,
online meetings were held) of 2–3 h of duration with specific tasks for each meeting: (1) Scope analysis;
(2) situation analysis—“strengths, weaknesses, opportunities, threats” (SWOT); (3) development and
improvement of methodology; and (4) final development of the pilot action plan (see Figure 1).
Table 1. Local implementation working groups; core set of participants and their relevant tasks and
responsibilities.
Participants
• Organizer
# Plan, prepare, chair and run the group workshops
# Run the secretariat (prepare agendas and minutes)
# Write reports
• Experts
# Provide knowledge and faculty on specific matters depending on the intervention selected
• Decision makers
# Provide strategic vision
# Support and sponsorship of the implementation process
# Eliminate bottlenecks during the implementation process
• Front-line stakeholders
# Give knowledge and expertise on real-life practice experience
# Choose the right type of subject to implement
# Motivate and empower implementers
# Equip and support implementers to deal with the implementation
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Table 1. Cont.
Participants
• Implementers (can be same individuals as the front-line stakeholders)
# Implement the intervention following the agreed plan
# Continuously assess the implementation process
# Provide input and feedback to the local implementation group
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2.3.1. Implementation Strategy Step 1: Scope Analysis
During the scope analysis, each local implementation working group selected the specific features
or elements of their planned intervention, which were identified according to their health context
and local n eds, i teres s, and capabiliti s. A structured group discussion was used. Although the
criteria for defining the scope could differ between sites, they generally followed five steps: (1) Identify
and describe the problem/challenge; (2) describe the general purpose of the intervention; (3) describe
the target population; (4) analyze the intervention’s components and identify the central features
that are essential to achieve the desired results; and (5) select the components from the Integrated
Multimorbidity Care Model that will be locally implemented.
2.3.2. Implementation Strategy Step 2: SWOT Analysis
Situation analysis—“strengths, weaknesses, opportunities, threats” (SWOT)—was used to identify
the respective organizations’ internal strengths and weaknesses, as well as external opportunities for,
and threats to, implementing the interventions based on the selected model elements. SWOT is designed
to help with both strategic planning and decision making in relation to the planned intervention.
SWOT was chosen as a tool because it is a structured method that is comparable. This allowed us to
compare the different analyses from the five sites.
During the SWOT analysis, the working groups considered the strengths, weaknesses, opportunities,
and threats to their proposed Integrated Multimorbidity Care Model across five dimensions:
(1) Sustainability; (2) organization; (3) empowerment; (4) communication; and (5) monitoring and
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evaluation. A template was devised to facilitate discussion. All five sites prepared a matrix that presented
the most important strengths, weaknesses, opportunities, and threats for their organization, with an
overview of major issues, priorities, and strategic actions needed in relation to their planned intervention.
2.3.3. Implementation Strategy Steps 3 and 4: Development and Improvement of Methodology and
Final Development of Action Plans
The methodology was developed and improved by the five local working groups during the
face-to-face meetings, leading to the development of an action plan, which provides a concrete set of
steps and activities that need to be carried out in order to implement their respective care interventions.
An adapted version of the iterative cyclic nature of “collaborative methodology” [15] was used for
drafting the local action plans. According to this methodology, the working groups addressed three
main questions: (1) What are we trying to accomplish? (2) What changes can we make that will result
in a successful implementation of the Integrated Multimorbidity Care Model as well as improvement?
(3) How will we know that a change is an improvement? These questions were used to develop a
concrete action plan, which was devised in five steps (see Table 2).
Table 2. Five steps used to define Action Plans for the Integrated Multimorbidity Care Model.
Action Plan Steps
1. Identify the specific issues to work on
The central features or elements of the intervention to work were already selected during the definition of the
scope. These included components of the Integrated Multimorbidity Care Model [6].
2. Detect improvement areas
Based on the strengths, weaknesses, opportunities, threats (SWOT) analysis, the working groups identified
specific areas for improvement.
3. Define specific objectives
According to the improvement areas detected, the working groups developed achievable and realistic
objectives.
4. Develop the Change Package
Based on the improvement areas and the associated objectives, concrete activities were described in a “change
package”, which is a set of changes that lead to improvement and successful implementation of Integrated
Multimorbidity Care Model during the implementation phase. Each objective defined in the previous step
requires at least one activity.
5. Set key performance indicators
Key performance indicators were defined to ensure that the expected impact of the interventions can be
accurately measured. Depending on the site, the indicators could either be intermediate health-related
outcome measures, process indicators, or both. The targets had to be achievable and measurable. Existing data
was chosen to measure progress.
3. Results
The Integrated Multimorbidity Care Model is being implemented in five pilot sites from Spain
(the Andalusian Health System and the Aragon Health System), Lithuania (Vilnius University Hospital
Santaros Klinikos, VULSK, Vilnius and Hospital of Lithuanian University of Health Sciences Kauno
Klinikos, Kauno Klinikos, Kaunas), and Italy (Università Cattolica del Sacro Cuore (UCSC), Rome).
As described in the methods section, a survey was carried out at the start of the project to identify
characteristics of the participating centers before the implementation of the Integrated Multimorbidity
Care Model. Results of the survey revealed some common goals for the five pilot sites, such as to
increase multidisciplinary collaboration, promote evidence-based practice, and reduce inequalities in
access to care and support services. A summary of some of the characteristics of the sites is illustrated
in Table 3. All five pilot sites include a six-month run-in period (patient recruitment), followed by
a 12-month implementation period. Key indicators are measured at the end of the implementation.
JA CHRODIS-PLUS is a three-year project and the timescale of the interventions were chosen in order
to allow sufficient time for preparation, application of the intervention, and reporting. Most of the
implementers considered it important to involve general practitioners and nurses in delivering care to
patients. Indeed, the majority of patients are being identified via primary care settings. In all cases,
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the main care providers are either general practitioner physicians or nurses (or they are involved
in the multidisciplinary meetings). Case managers are appointed in the majority of interventions
(usually a physician) and many also include a social worker as part of the core multidisciplinary team.
All five sites report that their patients will undergo comprehensive assessment at the start and end
of the integrated care process, but few include a regular periodic assessment in-between. Most of
the programs reported some key common characteristics of the intervention and services, patient
education, follow-up visits, and referrals between medical specialties have been reported by all five
sites, and clinical (diagnostic/monitoring) tests in all but one. However, other characteristics of the
intervention and services differ somewhat between settings.
Most sites are using technology in their interventions. For example, four of the five sites offer
eHealth services and half of the multidisciplinary team meetings are conducted virtually. All five sites
reported using digital health care communication tools; these are mostly e-referral but there are also
other aspects like virtual conferences with patients and online appointment schedules. Three-quarters
of the sites have electronic systems for registering/monitoring care processes and all use electronic health
records. However, currently none of the programs use electronic decision support systems. The survey
also highlighted some noticeable absences, especially in terms of community and social resources.
In fact, only one site is directly supporting patients in accessing community and social resources.
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Table 3. Characteristics of the five pilot sites.
Andalusian Health System Aragon Health System UCSC-Rome VULSK Kauno Klinikos
Country Spain Spain Italy Lithuania Lithuania
Patients
Complex chronic patients
with multimorbidity (patients
with chronic severe health
problems, multimorbidity
and polypharmacy)
Patients with multimorbidity
(3+ diseases) and
polypharmacy (5+ drugs) or
complex
Adults with dementia or
Down syndrome and
multimorbidity
Patients with
multimorbidity
(2+ diseases)
Patients with multimorbidity
(2+ diseases)
Age No age limit ≥65 years
≥65 years Alzheimer
Disease patients
≥18 years Down
Syndrome patients
45–70 45–70
Target number
of patients
All complex chronic patients
with individualized care
plans initiated from
December 2018 to February
2019 all over the region
200 200 200 200
General aim
Assess the systematized
application of individualized
care plans to complex
chronic patients
Training of healthcare
professionals in
multimorbidity + integrated
care measures
Improve case
coordination, and provide
patients with a reference
care provider
(+Technocare)
To improve the quality of
life, decrease the number
of potentially avoidable
hospitalizations/readmissions
and improve quality of
multimorbid patient care
To improve the quality of life,
decrease the number of
potentially avoidable
hospitalizations/readmissions
and improve quality of
multimorbid patient care
Setting Primary care centersin the region
13 primary care health centers
+1 hospital of reference Outpatient clinic
Different primary care
health centers
(1 public, 1 private)
Different primary care health
centers (1 urban, 1 rural)
Implementation All of the five pilot sites include a six-month run-in period (patient recruitment), followed by a 12-month implementation period
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3.1. Components in the Planned Interventions
The five sites were required to implement at least one component from the 2018 Multimorbidity
Care Model proposed by JA-CHRODIS [6], which proposed 16 components. Table 4 describes which
elements were chosen to be included in each site’s intervention. Kauno Klinikos are implementing
13 of the 16 components and three sites (Kauno Klinikos, UCSC-Rome, and VULSK) are including
components from all of the five domains. The Andalusian Health System’ intervention focuses only on
the “individualized care plan” component; other components are already in place in this region. Most
sites (four out of five) include regular, comprehensive assessment of patients, a multidisciplinary team,
a case manager, individualized care plans, and shared decision making between patients and care
providers. Only one site (Aragon Health System) is providing training to care providers on supporting
patient self-management, while another (UCSC-Rome) includes patient operated technologies that allow
patients to send information to their care providers. In the Andalusian Health System, the Observatory
of Innovative Practices for Complex Chronic Diseases Management (OPIMEC) [16] already provides
online knowledge exchange and training to professionals involved in the management and treatment
of complex chronic patients on a regular basis.
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Table 4. Components of the Integrated Multimorbidity Care Model that will be applied in each of the interventions.
Andalusian Health System 1 Aragon Health System UCSC-Rome VULSK Kauno Klinikos
Delivery of the care model system
Regular comprehensive assessment of patients Yes Yes Yes Yes
Multidisciplinary, coordinated team Yes Yes Yes Yes
Professional appointed as coordinator of the individualized care
plan (“case manager”) Yes Yes Yes Yes
Individualized care plans Yes Yes Yes Yes
Decision support
Implementation of evidence-based practice Yes Yes
Training members of the multidisciplinary team Yes Yes Yes
Developing a consultation system to consult professional experts Yes Yes Yes
Self-management support
Training of care providers to self-management support Yes
Providing options for patients and families to improve their
self-management Yes Yes Yes
Shared decision making (care provider and patients) Yes Yes Yes Yes
Information systems and technology
Electronic patient records and computerized clinical charts Yes Yes
Exchange of information between care providers and sectors by
clinical information systems Yes Yes
Uniform coding of patients’ health problems where possible Yes
Patient-operated technology allowing patients to send information
to their care providers Yes
Social and community resources
Supporting access to community- and social- resources Yes
Involvement of social network (informal), including friends,
patient associations, family, neighbors Yes Yes
1 The Andalusian Health System already has other components of the Integrated Multimorbidity Care Model in place.
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3.2. Description of Pilot Sites
The Andalusian Health System: “Implementation of a ‘personalized action plan’ within the strategy
and comprehensive plan for complex chronic patients”.
The “Consejería de Salud y Familias de la Junta de Andalucía” is implementing their Integrated
Multimorbidity Care Model in primary care centers all over this region of Spain. The implementation
is linked with the healthcare strategy for complex chronic patients, within the framework of the
Andalusian comprehensive healthcare plan for patients with chronic diseases. The plan focuses on
enhancing community care (primary healthcare), intra-level coordination, and continuity of care (using a
liaison nurse). The objectives of the care model are to: increase multidisciplinary collaboration, improve
patients and informal careers involvement, improve functional status, decrease and delay complications,
to reduce inequalities in access to care and support services, and reduce hospital admissions and
acute care visits. The intervention targets one component of the Integrated Multimorbidity Care
Model (see Table 4), namely individualized care plans, although other components of the model are
already in place. The specific aim of the intervention is to assess the influence of the systematized
application of individualized and comprehensive care plans to complex chronic patients (patients with
chronic severe health problems, multimorbidity, and polypharmacy). All complex chronic patients
with individualized care plans started and delivered between December 2018 and February 2019 were
selected as the target population and will be followed for one year. Regular training of healthcare
professionals is provided through the OPIMEC platform [16].
The Aragon Health System: “Aragon primary care”.
The model is being implemented in a total of 13 primary health care centers in the Aragon
Health System. A total of 43 healthcare professionals (21 general practitioners, 18 primary care
nurses, 2 internal medicine specialists, and 2 internal medicine nurses) from 13 health care centers
and 1 hospital, with a long professional experience, have been trained in multimorbidity through the
eMulti-PAP course developed within the framework of the Multi-PAP randomized control trial [17].
A total of 291 high risk multimorbid patients from their respective practices have been selected
and included in the piloting. The main aim is to examine the feasibility of implementing this type
of intervention in a real context and to decrease the impact of multimorbidity on health outcomes
in patients aged 65 years and over with multimorbidity (≥3 chronic diseases) and polypharmacy
(≥5 drugs). The main objectives of the care model are to: promote evidence-based practice, reduce
inequalities in access to care and support services, prevent or reduce misuse of services, increase
multidisciplinary collaboration, and decrease morbidity. The intervention targets eleven components
of the Integrated Multimorbidity Care Model (see Table 4) from all domains. They include training for
healthcare providers, appointment of a case manager, use of individualized care plans, development of
a virtual inter-consultation system, and supporting access to community resources.
UCSC-Rome outpatient clinic in the Catholic University of the Sacred Heart, Rome, Italy:
“Multimorbidity care model in elders with dementia and adults with intellectual disability”.
UCSC-Rome are implementing their model in a national health service run tertiary care hospital
(Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli) in
Rome, Italy. The clinical government unit is mainly involved in this project together with the center
for ageing medicine (Centro Medicina dell’Invecchiamento). The care model is carried out in a day
hospital and focuses on ageing, frail patients with intellectual disability, comorbidity/multimorbidity,
and cognitive impairment. The aim of the intervention is to improve coordination and provide patients
with a reference care provider as well as to increase accessibility of care through a Technocare service
and enhance self-management through patient-operated technology. The main objectives of the care
model are to: improve professional knowledge on multimorbidity, reduce inequalities in access to care
and support services, improve accessibility of services, improve care coordination and integration of
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different units (within the organization), increase multidisciplinary collaboration, identifying target
group patients, improve patient and informal career involvement, and reduce hospital admissions and
acute care visits. The intervention will target nine components of the Integrated Multimorbidity Care
Model (see Table 4), from all five domains.
Kauno Klinikos: Kauno clinics primary healthcare center and Kaltinenai primary healthcare center,
Kaunas, Lithuania.
Kauno Klinikos is implementing the care model in the family medicine department of a tertiary
university clinic located in the second largest Lithuanian city. It provides all scope of primary care services
and is in close relation with other health sectors: secondary and tertiary as well. The target population
includes patients with multimorbidity aged 45–70, identified by GPs. The aim of the intervention is to test
the Integrated Multimorbidity Care Model patients in Lithuania to provide better care for multimorbid
patients and improve their quality of life, decrease the number of potentially avoidable hospitalizations
and readmissions, to elaborate economical evaluation of the expenditure for the multimorbid patients.
The main objectives are to: reduce adverse outcomes related to the presence of multiple diseases and the
risk of drug-drug interactions by elaborating individualized integrated care plans, optimize treatment,
maintenance, and healthcare resources by coordinating individualized integrated care plans; maximize
outcomes and increase continuity of care while decreasing fragmentation and optimizing access to care
and services through a case manager, who will intermediate between a patient and various members of
the multidisciplinary team; provide doctor-to-doctor decision support in situations where further clinical
support or knowledge is needed outside of the core team through a consultation system to be advised by
professional experts; and improve the patient‘s access to community resources, formal care, and patient
associations, support groups, and psychosocial support by providing multidisciplinary care both in
terms of different levels of the healthcare profession (nurses, physicians, physiotherapists, social workers
etc.), and different disease specializations. The intervention targets 13 components of the Integrated
Multimorbidity Care Model (see Table 4), from all five domains.
VULSK family medicine center primary care setting at Vilnius University Hospital Santaros Klinikos,
Vilnius, Lithuania: “Family medicine center, primary care”.
VULSK is implementing the care model in primary care but is also expanding beyond the primary
care setting, to include the secondary and tertiary care physicians, aiming to create teams who manage
the patient. It is aimed at multimorbid patients attending primary care settings. The main objective
of the program is to promote evidence-based practice to primary care multimorbid patients with the
aim to improve their quality of life, decrease the number of potentially avoidable hospitalizations and
readmissions, and elaborate economical evaluation of the expenditure for the multimorbid patients.
The intervention targets 10 components of the Integrated Multimorbidity Care Model (see Table 4)
from all five domains. In particular, it includes all components from the delivery of care model
and the decision support components. The specific aims of the intervention include to: (1) Reduce
adverse outcomes related to the presence of multiple diseases and the risk of drug-drug interactions by
elaborating individualized integrated care plans; (2) optimize treatment, maintenance, and healthcare
resources by coordinating individualized integrated care plan; (3) maximize outcomes and increase
continuity of care while decreasing fragmentation and optimizing access to care and services through a
case manager; (4) provide doctor-to-doctor decision support in situations where further clinical support
or knowledge is needed outside of the core team through a consultation system of professional experts;
(5) improve the patient‘s access to community resources, formal care, and patient associations, support
groups, and psychosocial support by providing multidisciplinary care both in terms of different levels
of the healthcare profession and different disease specializations.
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3.3. Key Performance Indicators
During development of the action plans, each pilot site defined key performance indictors to
measure the success of the respective interventions. A common approach was chosen for assessing the
impact of the interventions that consisted both of a quantitative and qualitative analysis. The specific
key performance indicators for each site are described in Table 5. There were some common indicators
between sites, particularly Kauno Klinikos and VULSK, who defined a similar set of indicators.
The Assessment of Chronic Illness Care (ACIC) [18] questionnaire was chosen as an appropriate
quantitative measure. ACIC is responsive to changes that care teams make in their healthcare systems
and correlates well with other measures of productivity and system change. It consists of six
elements that were proposed in the Chronic Care Model, namely; health care organization; community
linkages; self-management support; decision support; delivery system design; and clinical information
systems. The Patient Assessment of Care for Chronic Conditions+ (PACIC+) [19] was also selected for
quantitative measuring outcomes of the interventions. This tool measures specific actions or qualities
of care that patients report they have experienced during the intervention. The actions are congruent
with the Chronic CareModel and consist of 26 items. Both instruments will be collected and analyzed
pre- and post-implementation.
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Table 5. Specific key performance indicators at five pilot sites that are implementing an Integrated Multimorbidity Care Model: intermediate health-related outcome
measures and process indicators.
Andalusian Health System Aragon Health System UCSC-Rome Kauno Klinikos and VULSK
PROCESS INDICATORS
Number of health districts participating
in the pilot
Drawing up and delivering the
ndividualized care plans
Number of primary care units involved
Number of visits of complex chronic
patients with individualized care plans to
primary healthcare centers in 12 months
Number of health care professional team
meetings related to individualized care
plans in 12 months
Quality of performed individualized
care plans
PROCESS INDICATORS
Existence of a document describing the
functions/role of the case manager
Percentage of patients included in the
program with case manager identified
Number of primary care teams included
in the program
Implementation of a chronic care unit at
the hospital
Identification of personnel of reference at
hospital’s chronic care unit
Number of health professionals who
accept to do/start/finish
the training course
Improvement of knowledge and skills in
multimorbidity after the training course
Existence of a module of information
shared among professionals in the
electronic health records
Percentage of response to
inter-consultations in less than 96 h
Availability of direct and specific
communication channels between
chronic patients and their case managers
Social support/needs assessment
Identification and mapping of
community assets
PROCESS INDICATORS
A survey will be administered in the
outpatient context at the start of the
quality improvement intervention and
10 months after the rollout process
Reduction of unnecessary referrals
Percentage of dropouts (number of
missing appointments by patients with
AD and DS/number of fixed
appointments for patients with AD and
DS) calculated as an index for poor
coordination of care
Average number of Technocare contacts
recorded in 12 months
Percentage of extra Technocare contacts
for Lazio region
Percentage of Technocare dropouts
(percentage of patients with AD and DS
who disattend the fixed Technocare
appointment/number of patients with
AD and DS who fixed
Technocare appointment)
Percentage of rescheduled techno visits
(percentage of rescheduled visits for
patients with AD and DS/number of
patients with AD and DS who fixed
Technocare appointment
Number of patients with AD and DS that
participate in the group meeting
PROCESS INDICATORS
Existence of a guidelines that describes
the role of case manager
% of patients with individualized care
plan based on a
comprehensive assessment
Number of visits to primary care team in
12 months per patient
Number of consultations in 12 months
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Table 5. Cont.
Andalusian Health System Aragon Health System UCSC-Rome Kauno Klinikos and VULSK
IMMEDIATE HEALTH-
RELATED OUTCOMES
ACIC and PACIC+
Inpatient episodes of complex chronic
patients with individualized care plans
in 12 months
Outpatient visits of complex chronic
patients with individualized care plans
in 12 months
Emergency episodes of complex chronic
patients with individualized care plans
in 12 months
Rate of unplanned hospitalization
potentially preventable achieved
in 12 months
IMMEDIATE HEALTH-
RELATED OUTCOMES
ACIC
Number of admissions to the emergency
room in 12 months
Number of hospitalizations in 12 months
Number of hospitalizations at chronic
care unit/total hospitalizations
Satisfaction of the training course by
health professionals and self-perceived
applicability in clinical practice
Percentage of inter-consultations
Percentage of patients with
individualized care plan based on a
comprehensive assessment
Prevalence of polymedicated and
hyper-polymedicated patients
IMMEDIATE HEALTH-
RELATED OUTCOMES
ACIC and PACIC+
Reduction of accessibility in Emergency
Department and subsequent
hospitalizations
IMMEDIATE HEALTH-
RELATED OUTCOMES
ACIC and PACIC+
Number of unplanned visits
in 12 months
Number and duration of
hospitalizations, admissions to
emergency room, and avoidable
hospitalizations in 12 months
Number of incompatible drugs
combination (drug interaction rate)
-EQ-5D questionnaire is a standardized
instrument developed by the EuroQol
Group as a measure of health-related
quality of life
-The EQ VAS records the patient’s
self-rated health on a vertical visual
analogue scale
AD: Alzheimer disease, DS: Down Syndrome, PACIC+: The Patient Assessment of Care for Chronic Conditions+, ACIC: Assessment of Chronic Illness Care questionnaire, EQ VAS:
EuroQol-visual analogue scales, EQ-5D: EuroQol 5D.
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4. Discussion
In this article we describe the methods of the pre-implementation phase of five pilot sites who
are implementing an Integrated Multimorbidity Care Model as part of JA CHRODIS-PLUS. Key
stages of the pre-implementation phase include the establishment of a local implementation working
group, patient risk stratification, scope analysis, SWOT analysis, development and improvement of
methodology, and final development of the pilot action plan. Characteristics of the five pilot sites
and their specific interventions are described in terms of the intervention’s main aim and objectives,
settings and patients, and key quality and performance indicators. This common implementation
strategy serves to show how care models can be adapted according to local and regional specificities.
There are several strengths of the methodology. We used a process that followed a standardized
procedure that could be adapted according to the local site’s needs, capabilities, and characteristics.
The process was developed so that each site followed the same methodology in order to create
standardized implementation package that can be practically applied in different European and clinical
settings. Each of the five sites participated in regular joint meetings (usually virtually) with the
Work Package coordinators to compare strategies and identify any unclarities in the methodology.
In addition, we used tools such as SWOT analysis that can provide comparable information that
identify differences and similarities across sites.
There are potential limitations to the implementation process described herein. First, the
implementation process was set at 18 months in order to fit within the timeframe of the three-year JA
CHRODIS-PLUS project. Therefore, various aspects such as the selected key indicators might reflect
this relatively short intervention period. Longer interventions might have the potential to assess other
relevant health related indicators such as mortality, change in frailty status, or long-term functional
status, as well as economical and cost-effectives data. In addition, some of the key indicators need to
be interpreted carefully. For example, in the two Lithuanian sites we will measure the number of visits
to primary care and the number of consultations over the year-long intervention. One of the aims of
the intervention is to reduce hospitalizations and emergency rooms visits and this might mean that
primary care visits increase as a result. Therefore, careful interpretation of the significance of a change
in primary care visits and what this means in terms of economical and clinical impact is needed.
The current pilot testing of the Integrated Multimorbidity Care Model in five European sites is
expected to provide relevant information that should help in developing integrated care and treatment
programs for multimorbid patients. Currently, there is little information in the scientific literature
on such interventions [4,20]. Importantly, existing interventions for multimorbid patients frequently
apply different methods and care components, making it a challenge to compare strategies. Further, as
previous interventions have been applied in a range of counties, with many in the USA [4,20], it is
challenging to identify how such models and their components can be applied in different settings,
including Europe. Our project aims to bridge that gap by describing integrated care models that
have been implemented with a common strategy in different counties and in various care settings
(from primary care to outpatient clinics).
The eventual results of our study may contribute to the knowledge being currently built in other
ongoing trials in Europe; specifically two cluster randomized trials in Spain and the UK [17,21]. Results
from the UK-based “3D” trial [21] suggest that an intervention on multimorbid patients in primary care
consisting of 6-monthly comprehensive reviews did not improve patients’ quality of life or perceived
illness burden or treatment burden. Rather than disease focused care, they administered a patient
centered care model focused on improving the continuity, coordination, and efficiency of care via
comprehensive multidisciplinary assessments twice-yearly. However, although the results of the trial
were not successful in terms of improving patient outcomes, it has been noted that the study did not apply
patient stratification techniques that might help to identify the most demanding and complex-to-treat
groups, who would possibly benefit more from the care intervention [14] (e.g., stratifying according
to patterns of different diseases and symptoms or selecting according to specific physical, cognitive,
or socioeconomic factors). Other trials, such as the Spanish Multi-PAP project [17] may provide more
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insight; this study selects patients on the basis of both multimorbidity and polypharmacy. The trial
aims to examine the effectiveness of an intervention for improving drug prescriptions and includes
an intervention consisting of family-physician training (including concepts such as multimorbidity,
appropriate prescribing, and shared decision making) as well as a physician-patient interview based
on Ariadne principles (a model of care based on comprehensive assessment that takes into account also
the context and preferences of the patient). The Multi-PAPtrial is one of the few studies of this kind that
specifically investigates a training element for healthcare professionals and thus these results, together
with those from our pilot sites, will provide a more thorough picture of the elements of integrated care
that can lead to successful outcomes in multimorbid patients.
In conclusion, the five Integrated Multimorbidity Care Models described in the current paper are
currently in the implementation phase and most are due to last for 12 months. Analysis of the common
key indicators at the post-implementation phase will help to demonstrate the clinical effectiveness
of the care models as well as highlight any difficulties in adapting a common care model in different
countries and clinical settings. This information should help to guide future healthcare institutions
who wish to implement an Integrated Multimorbidity Care Model in their clinical setting.
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